To test whether the inhibition of mTOR induces MEK/MAPK activation in colon cancer cells, LS174T and SW480 cells were treated with rapamycin, PP242 or NVP-BEZ235 and the phosphorylation of MAPK was assessed by Western blot. Here, MTOR is linked to malignant colon neoplasm.